Search research articles
Contact Us
Filters
Showing results (31-40 of 146) with videos related to
Page
of 15
Sort By:
AJR. American Journal of Roentgenology
|
December 25, 2014
CT-guided fine-needle aspiration and core needle biopsies of pulmonary lesions: a single-center experience with 750 biopsies in Japan
Jumpei Takeshita, Katsuhiro Masago, Ryoji Kato, et al.
Oncology Letters
|
June 22, 2018
Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors
Satoru Nishizawa, Hideo Araki, Yoshinori Ishikawa, et al.
Journal of Palliative Medicine
|
June 2, 2012
Medroxyprogesterone acetate for refractory emesis in cisplatin-treated patients
Akito Hata, Nobuyuki Katakami, Shiro Fujita, et al.
Bioanalysis
|
May 16, 2019
Development of an LC-MS/MS-based method for quantitation of osimertinib in human plasma and cerebrospinal fluid
Kei Irie, Shigeki Nanjo, Akito Hata, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry
|
June 13, 2014
PNA-tagged peptide microarrays for ratiometric activity detection of cellular protein kinases
Hiromu Ikeda, Yoshihiro Yayama, Akito Hata, et al.
Internal Medicine (Tokyo, Japan)
|
March 28, 2012
Gefitinib for a poor performance status patient with squamous cell carcinoma of the lung harboring EGFR mutation
Kosuke Tanaka, Akito Hata, Yoko Kida, et al.
Anticancer Research
|
May 7, 2017
PD-L1 Expression in Patients with Non-small Cell Lung Cancer
Katsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 3, 2024
Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study
Misato Kariya, Kazuhiro Yamamoto, Akira Kawamura, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2015
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
Kyoko Otsuka, Akito Hata, Jumpei Takeshita, et al.
Anticancer Research
|
December 16, 2014
Clinicopathological factors affecting progression-free survival of patients with previously treated advanced non-small cell lung cancer after S-1 therapy with or without bevacizumab
Katsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 146) with videos related to
Sort By:
Page
of 15
AJR. American Journal of Roentgenology
|
December 25, 2014
CT-guided fine-needle aspiration and core needle biopsies of pulmonary lesions: a single-center experience with 750 biopsies in Japan
Jumpei Takeshita, Katsuhiro Masago, Ryoji Kato, et al.
Oncology Letters
|
June 22, 2018
Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors
Satoru Nishizawa, Hideo Araki, Yoshinori Ishikawa, et al.
Journal of Palliative Medicine
|
June 2, 2012
Medroxyprogesterone acetate for refractory emesis in cisplatin-treated patients
Akito Hata, Nobuyuki Katakami, Shiro Fujita, et al.
Bioanalysis
|
May 16, 2019
Development of an LC-MS/MS-based method for quantitation of osimertinib in human plasma and cerebrospinal fluid
Kei Irie, Shigeki Nanjo, Akito Hata, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry
|
June 13, 2014
PNA-tagged peptide microarrays for ratiometric activity detection of cellular protein kinases
Hiromu Ikeda, Yoshihiro Yayama, Akito Hata, et al.
Internal Medicine (Tokyo, Japan)
|
March 28, 2012
Gefitinib for a poor performance status patient with squamous cell carcinoma of the lung harboring EGFR mutation
Kosuke Tanaka, Akito Hata, Yoko Kida, et al.
Anticancer Research
|
May 7, 2017
PD-L1 Expression in Patients with Non-small Cell Lung Cancer
Katsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 3, 2024
Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study
Misato Kariya, Kazuhiro Yamamoto, Akira Kawamura, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2015
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
Kyoko Otsuka, Akito Hata, Jumpei Takeshita, et al.
Anticancer Research
|
December 16, 2014
Clinicopathological factors affecting progression-free survival of patients with previously treated advanced non-small cell lung cancer after S-1 therapy with or without bevacizumab
Katsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Page
of 15